CompoAtlas

HUILE ESSENTIELLE CAMOMILLE MATRICAIRE BIO

Food supplement declared in France, declaration No 2019-10-219

HUILE ESSENTIELLE CAMOMILLE MATRICAIRE BIO, from LABORATOIRE PERRIGO FRANCE, is a food supplement declared in France. Status: earlier declaration, replaced by the 2022 declaration. Main ingredients: Matricaria chamomilla 111 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRE PERRIGO FRANCE
Status
Earlier declaration, replaced by the 2022 declaration : HUILE ESSENTIELLE CAMOMILLE MATRICAIRE BIO
Form
Dropper
Daily dose
111mg
Directions for use
Adultes : 1goutte, 3 fois/j; Enfants de+de7ans : 1 goutte, 1fois/jr
Not recommended (according to the manufacturer)
Breastfeeding women, Young children (aged 1 to 3), Pregnant women, Infants (under 1 year)

Declaration 215003, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Matricaria chamomilla L.Essence (parties aériennes)Distillation111 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. A prendre en complément d’une alimentation variée et équilibrée et d’un mode de vie sain. Tenir hors de portée des jeunes enfants Ne pas utiliser chez les enfants de moins de 7 ans. Ne pas utiliser chez les femmes enceintes ou allaitantes, les personnes ayant des antécédents épileptiques ou convulsifs, les personnes hypersensibles aux Huiles Essentielles. Déconseillé aux personnes asthmatiques. Risques d'allergies. Demandez conseil à un professionnel de santé en cas de prise simultanée de médicaments. Ne jamais prendre pure par voie orale sans support. Ne jamais prendre plus de 2 gouttes par prise, ni plus de 8 gouttes par jour d’Huile(s) Essentielle(s). Pour toute autre utilisation, demandez conseil à votre pharmacien.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Matricaria chamomilla L.
    Read the warning, when it applies and the studies cited

    GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000; WHO 1999; Bradley 1992).

    Cautions and warnings

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. 2003. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Health Canada monograph dated 19 December 2025

    German Chamomile - Matricaria Chamomilla Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 31 January 2025

    GERMAN CHAMOMILE - MATRICARIA CHAMOMILLA Buccal

    Route of administration: Buccal (ESCOP 2003; Blumenthal et al. 2000; Bradley 1992)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line